Remote versus face-to-face monitoring for implantable cardiac devices: Rationale and design of the PORTLink (PORTuguese research on telemonitoring with CareLink);Monitorização à distância versus seguimento convencional presencial em portadores de dispositivos cardíacos implantados: Racional e desenho do estudo PORTLink (PORTuguese research on telemonitoring with CareLink)

Revista Portuguesa de Cardiologia

Volumn 32, Issue 12, 2013, Pages 957-964

  Oliveira, Mário ^a   Fernandes, Milene ^b   Primo, João ^c   Reis, Hipólito ^d   Nicola, Paulo ^b  

^a Centro Hospitalar de Lisboa Central Maternidade   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^c CENTRO HOSPITALAR DE VILA NOVA DE GAIA ESPINHO   (Portugal)

^d Centro Hospitalar e Universitário do Porto   (Portugal)

Author keywords

Cardiacresyn chronization therapy; Carelink; Follow up; Implantable cardioverter defibrillator; Remote monitoring

Indexed keywords

ANXIETY; ARTICLE; CARDIAC IMPLANT; CARDIAC IMPLANTABLE ELECTRONIC DEVICE; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEPRESSION; FOLLOW UP; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL CARE; MULTICENTER STUDY; PATIENT ATTITUDE; PATIENT MONITORING; PATIENT SAFETY; PATIENT SATISFACTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TELEMONITORING; CLINICAL TRIAL; COMPARATIVE STUDY; DEVICES; EQUIPMENT DESIGN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; METHODOLOGY; PHYSIOLOGIC MONITORING; PROCEDURES; PROSPECTIVE STUDY; TELEMETRY;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT DESIGN; HUMANS; MONITORING, PHYSIOLOGIC; PROSPECTIVE STUDIES; RESEARCH DESIGN; TELEMETRY;

EID: 84893104715     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.repc.2013.06.009     Document Type: Article

References (31)

1. Christoph Stellbrink, Hans-Joachim Trappe. The follow-up ofcardiac devices: What to expect for the future? Eur Heart JSuppl. 2007;9 suppl I:113-5.
2. Theuns AMJ, Jordaens LS. Remote monitoring in implantabledefibrillator therapy. Neth Heart J. 2008;16:53-6.
3. Maisel W, Moynahan M, Zuckerman D, et al. Pacemaker and ICDgenerator malfunctions: analysis of Food and Drug Administra-tion Annual Reports. JAMA. 2006;295:1901-6.
4. P. Vardas, A. Auricchio, C. Wolpert. The EHRA White Book 2010. The Current Status of Cardiac Electrophysiology in ESC MemberCountries; pp. 305-14.
5. John Camm A, Nisam S. European utilization of the implanta-ble defibrillator: Has 10 years changed the 'enigma'? Europace. 2010;12:1063-9.
6. Fonarow GC, Yancy CW, Hernandez AF, et al. Poten-tial impact of optimal implementation of evidence-basedheart failure therapies on mortality. Am Heart J. 2011;161:1024-30.
7. Nielsen JC, Kottkamp H, Zabel M, et al. Automatic home moni-toring of implantable cardioverter defibrillators. Europace. 2008;10:729-35.
8. Senges-Becker JC, Klostermann M, Becker R, et al. What isthe ''Optimal'' follow-up schedule for ICD patients? Europace. 2005;7:319-26.
9. Chauvin M, Frank R, le Heuzey J, et al. Guidelines for theimplantation and follow-up of automatic cardioverter defi-brillators. Archives des Maladies du Coeur et des Vaisseaux,Septembre. 2004;97:915-9.
10. Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expertconsensus on the monitoring of cardiovascular implantable elec-tronic devices (CIEDs): Description of techniques, indications,personnel, frequency and ethical considerations. Heart Rhythm. 2008;5:907-25.
11. Raatikainen MJ, Uusimaa P, van Ginneken MM, et al. Remotemonitoring of implantable cardioverter defibrillator patients:A safe, time-saving, and cost-effective means for follow-up. Europace. 2008;10:1145-51.
12. Varma N, Epstein AE, Irimpen A, et al. Efficacy andsafety of automatic remote monitoring for implantablecardioverter-defibrillator follow-up: The Lumos-T Safely Redu-ces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325-32.
13. Pais-Ribeiro J, Silva I, Ferreira T, et al. Validation study of a Por-tuguese version of the Hospital Anxiety and Depression Scale. Psychology, Health and Medicine. 2007;2:225-37.
14. Ware Jr JE, Kosinski M, Keller SD. 12-item short-form healthsurvey: Construction of scales and preliminary tests of reliabilityand validity. Medical Care. 1996;34:220-33.
15. Vlay SC. The ACC/AHA/HRS 2008 Guidelines for Device-basedTherapy of Cardiac Rhythm Abnormalities: Their Relevance tothe Cardiologist, Internist and Family Physician. J Invasive Car-diol. 2009;21:234-7.
16. Nanthakumar K, Epstein AE, Kay GN, et al. Prophylac-tic implantable cardioverter-defibrillator therapy in patientswith left ventricular systolic dysfunction. J Am Coll Cardiol. 2004;44:2166-72.
17. Eucomed. Statistics for Cardiac Rhythm Management pro-ducts, 2005-2010 [consultado 18 Jan 2012]. Disponível em:http://www. eucomed. org
18. Heidbuchel H, Lioen P, Foulon S, et al. Potential role ofremote monitoring for scheduled and unscheduled evaluati-ons of patients with an implantable defibrillator. Europace. 2008;10:351-7.
19. Crossley G, Boyle A, Vitense H, et al. , CONNECT Investiga-tors. The CONNECT (clinical evaluation of remote notificationto reduce time to clinical decision) Trial: The value of wirelessremote monitoring with automatic clinician alerts. J Am CollCardiol. 2011;57:1181-2118.
20. Spencker S, Coban N, Koch L, et al. Potential role of homemonitoring to reduce inappropriate shocks in implantablecardioverter-defibrillator patients due to lead failure. Euro-pace. 2009;11:483-8.
21. Costa PD, Rodrigues PP, Reis AH, et al. A Review onremote monitoring technology applied to implantable elec-tronic cardiovascular devices. Telemed J E Health. 2010;16:1042-50.
22. Elsner CH, Sommer P, Piorkowski C, et al. A Prospective mul-ticentre comparison trial of home monitoring against regularfollow-up in MADIT II Patients: Additional visits and cost impact. Computers in Cardiology. 2006;33:241-4.
23. Masella C, Zanaboni P, di Stasi F, et al. Assessment of a remotemonitoring system for implantable cardioverter defibrillators. J Telemed Telecare. 2008;14:290-4.
24. Stafford W, Glenn Y, Russel D, et al. Performance and bene-fits of remote device follow-up with CareLink. Heart Lung Cir. 2009;18(s3):266-7.
25. Varma N. Therapeutic implications of automatic home moni-toring of implantable cardiac devices. Curr Treat OptionsCardiovasc Med. 2009;11:366-72.
26. Burri H, Heidbüchel H, Jung W, et al. Remote monitoring: A costor an investment? Europace. 2011;13 Suppl 2:44-8.
27. Marzegalli M, Lunati M, Landolina M, et al. RemoteMonitoring of CRT-ICD: The Multicenter Italian CareLinkEvaluation - ease of use, acceptance, and organizational impli-cations. PACE. 2008;31:1259-64.
28. Ricci RP, Morichelli L, Quarta L, et al. Long-term patientacceptance of and satisfaction with implanted device remotemonitoring. Europace. 2010;12:674-9.
29. Crossley G, Chen J, Choucair W, et al. Clinical benefits of remoteversus transtelephonic monitoring of implanted pacemakers. J Am Coll Cardiol. 2009;54:2012-9.
30. Base de Dados dos Elementos Analíticos da Administraç ãoCentral do Sistema de Saúde (ACSS). Dispoível em:http://www. acss. min-saude. pt/bdea/
31. Portaria 163/2013. Diário da República, 1. asérie - N. (80 - 24de abril de 2013.